Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01315106 · ClinicalTrials.gov registry record
High Resolution 3D Diffusion-weighted Breast MRI
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 50
- Enrollment target
NCT01315106: Clinical Trial study, sponsored by Stanford University.
NCT01315106 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01315106 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how well a new MRI technique called "High resolution 3D diffusion-weighted breast MRI" detects breast cancer.
Interventions
- DEVICE Magnetic Resonance Image Scanner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2011-03 |
| Est. Completion | 2014-01-07 |
Why NCT01315106 stopped before completion
NCT01315106 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Magnetic Resonance Image Scanner is the first listed.
NCT01315106 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01315106 about?
NCT01315106 is a clinical study titled "High Resolution 3D Diffusion-weighted Breast MRI". The purpose of this study is to determine how well a new MRI technique called "High resolution 3D diffusion-weighted breast MRI" detects breast cancer.
What is the current status of trial NCT01315106?
This trial is currently terminated. The enrollment target is 50 participants. The study started on 2011-03. Estimated completion is 2014-01-07.
What interventions are being tested in trial NCT01315106?
The interventions under investigation include: Magnetic Resonance Image Scanner (DEVICE).
Who is sponsoring clinical trial NCT01315106?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia